Freeman Hospital

Meta-Analysis of Data from Trials of Machine Perfusion Technologies in Liver Transplantation Demonstrates Clinical Advantages of Hypothermic Oxygenated Machine Perfusion (HOPE), according to Bridge to Life Ltd.

Retrieved on: 
Mittwoch, Mai 1, 2024
DBD, FDA, Bile, SCS, NAS, HOPE, Systematic review, Meta-analysis, MP, Newcastle University, Transplant, Portal vein, Freeman Hospital, Research, Minuteman Library Network, Arrest, Brain death, GRADE, Liver, Patient, NMP, Health policy, Blood, Bias, Risk, Translation, Liver transplantation, DCD, Dietary supplement

CHICAGO, May 1, 2024 /PRNewswire/ -- Hypothermic oxygenated machine perfusion (HOPE) of livers awaiting transplantation provides significantly greater outcomes than normothermic machine perfusion (NMP) and ice-box static cold storage (SCS), according to a Cochrane review and meta-analysis of seven clinical trials. The analysis, Machine perfusion in liver transplantation; Cochrane review and meta-analysis, by Samuel James Tingle, MD, et al, Newcastle University, Translational and Clinical Research Institute, Newcastle, United Kingdom; Freeman Hospital, Institute of Transplantation, Newcastle, United Kingdom; Newcastle University, NIHR Blood and Transplant Research Unit, Newcastle, United Kingdom Newcastle University, Translational and Clinical Research Institute, Newcastle, United Kingdom, was shown today in a late-breaker session during The 2024 International Congress of the International Liver Transplantation Society (ILTS) in Houston, Texas.

Key Points: 
  • CHICAGO, May 1, 2024 /PRNewswire/ -- Hypothermic oxygenated machine perfusion (HOPE) of livers awaiting transplantation provides significantly greater outcomes than normothermic machine perfusion (NMP) and ice-box static cold storage (SCS), according to a Cochrane review and meta-analysis of seven clinical trials.
  • The analysis included seven randomized trials (1024 transplant recipients from 1301 randomized/included livers); four compared end-ischemic hypothermic oxygenated perfusion (HOPE) with SCS, and three compared normothermic machine perfusion (NMP) with SCS.
  • Machine perfusion (MP) is a novel method for organ graft preservation before transplantation.
  • In hypothermic oxygenated perfusion (HOPE), donor livers are perfused through the portal vein with a cold (4 °C), acellular, oxygenated fluid at low vascular pressures.

Adventist HealthCare's Lucy Byard Scholarships Provide $60,000 to Four D.C. Area Nursing Students

Retrieved on: 
Dienstag, August 1, 2023
Adventist HealthCare White Oak Medical Center, Howard University Hospital, Education, Adventist HealthCare, Adventist HealthCare Shady Grove Medical Center, Research, Freeman Hospital, Student, Portrait, Health, Nursing, Hospital, Silver, Adventism

GAITHERSBURG, Md., Aug. 1, 2023 /PRNewswire/ -- Adventist HealthCare has presented four exceptional D.C. area nursing students with 2023 Lucy Byard Scholarships totaling $60,000.

Key Points: 
  • GAITHERSBURG, Md., Aug. 1, 2023 /PRNewswire/ -- Adventist HealthCare has presented four exceptional D.C. area nursing students with 2023 Lucy Byard Scholarships totaling $60,000.
  • Adventist HealthCare launched the scholarship in 2022 to honor Lucy Byard and to help address economic, educational, and healthcare disparities.
  • The Lucy Byard Scholarship will help ease the financial burden on the students as they complete their nursing training.
  • Adventist HealthCare is establishing an endowment through philanthropic gifts to ensure its continued ability to award future Lucy Byard Scholarships.

Varian Highlights Comprehensive Cancer Care Portfolio at ESTRO 2022

Retrieved on: 
Donnerstag, Mai 5, 2022
Sola, Eclipse, European Society for Medical Oncology, Proton therapy, Thought, Proton, The Queen's Award for Enterprise: Innovation (Technology) (2002), Radiation, ARIA, Twitter, UC, Exhibition, Expert, Patient, UC San Diego Health, Siemens Healthineers, CT, CE, Diagnosis, Cancer, Medical examiner, Artificial intelligence, Connectivity, Afterload, Machine learning, Workflow, Radiation therapy, Database, Brachytherapy, Electron, Anatomy, Paradigm, Sale, Solution, Technology, Strathcona County, Freeman Hospital, Intelligence, Medical imaging, Medical device, Pharmaceutical industry, Varian, Ethos

PALO ALTO, Calif., May 5, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, will be showcasing its comprehensive cancer care portfolio at the 2022 annual meeting of the European Society for Radiotherapy and Oncology (ESTRO), starting tomorrow in Copenhagen, Denmark. The combined company's exhibit will highlight technologies that span the entire cancer care continuum, from screening and prevention, through diagnosis, therapy, and survivorship. In addition to driving speed and precision, these solutions seek to streamline workflows and empower cancer care teams to improve their clinical and operational performance and meet unique and evolving patient needs.

Key Points: 
  • Showcases Innovative Technologies and Services to Drive Personalization, Precision, and Connectivity Along the Radiotherapy Treatment Pathway
    PALO ALTO, Calif., May 5, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, will be showcasing its comprehensive cancer care portfolio at the 2022 annual meeting of the European Society for Radiotherapy and Oncology (ESTRO), starting tomorrow in Copenhagen, Denmark.
  • The combined company's exhibit will highlight technologies that span the entire cancer care continuum, from screening and prevention, through diagnosis, therapy, and survivorship.
  • Additional innovative solutions from Varian and Siemens Healthineers that will be showcased at ESTRO, include:
    ARIA oncology information system, which has been reimagined as a comprehensive cancer care management tool.
  • We are working to harness advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care.

Varian Highlights Comprehensive Cancer Care Portfolio at ESTRO 2022

Retrieved on: 
Donnerstag, Mai 5, 2022
Sola, Eclipse, European Society for Medical Oncology, Proton therapy, Thought, Proton, The Queen's Award for Enterprise: Innovation (Technology) (2002), Radiation, ARIA, Twitter, UC, Exhibition, Expert, Patient, UC San Diego Health, Siemens Healthineers, CT, CE, Diagnosis, Cancer, Medical examiner, Artificial intelligence, Connectivity, Afterload, Machine learning, Workflow, Radiation therapy, Database, Brachytherapy, Electron, Anatomy, Paradigm, Sale, Solution, Technology, Strathcona County, Freeman Hospital, Intelligence, Medical imaging, Medical device, Pharmaceutical industry, Varian, Ethos

PALO ALTO, Calif., May 5, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, will be showcasing its comprehensive cancer care portfolio at the 2022 annual meeting of the European Society for Radiotherapy and Oncology (ESTRO), starting tomorrow in Copenhagen, Denmark. The combined company's exhibit will highlight technologies that span the entire cancer care continuum, from screening and prevention, through diagnosis, therapy, and survivorship. In addition to driving speed and precision, these solutions seek to streamline workflows and empower cancer care teams to improve their clinical and operational performance and meet unique and evolving patient needs.

Key Points: 
  • Showcases Innovative Technologies and Services to Drive Personalization, Precision, and Connectivity Along the Radiotherapy Treatment Pathway
    PALO ALTO, Calif., May 5, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, will be showcasing its comprehensive cancer care portfolio at the 2022 annual meeting of the European Society for Radiotherapy and Oncology (ESTRO), starting tomorrow in Copenhagen, Denmark.
  • The combined company's exhibit will highlight technologies that span the entire cancer care continuum, from screening and prevention, through diagnosis, therapy, and survivorship.
  • Additional innovative solutions from Varian and Siemens Healthineers that will be showcased at ESTRO, include:
    ARIA oncology information system, which has been reimagined as a comprehensive cancer care management tool.
  • We are working to harness advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care.